Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fine Chemical Application Development Co., Ltd., commonly known as FADCO, is a Japanese chemical development company and a wholly-owned subsidiary of Nippon Kayaku. The company specializes in the research, development, and application of fine chemicals, particularly intermediates for pharmaceuticals, agrochemicals, and functional materials. FADCO operates as a contract development and manufacturing organization (CDMO), providing expertise in organic synthesis and process chemistry to support the commercialization of complex chemical entities. Its services range from laboratory-scale synthesis to process optimization and full-scale commercial production. The company is a key technical partner for its parent company's pharmaceutical division, especially in the production of oncology-related compounds. FADCO is headquartered in Tokyo and leverages the extensive manufacturing and R&D infrastructure of its parent organization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fine Chemical Application Development Corporation.